Role of Inflammasomes in Kidney Diseases Via Both Canonical and Non-canonical Pathways

Overview

Journal Front Cell Dev Biol

Specialty Cell Biology

Date 2020 Mar 17

PMID 32175320

Citations 39

Authors

Huiling Xiang

Feng Zhu

Zhifeng Xu

Jing Xiong

Affiliations

Soon will be listed here.

Abstract

Inflammasomes, multiprotein complex induced by harmful factors in the body, play a crucial role in innate immunity. Activation of inflammasomes lead to the activation of casepase-1 and then the secretion of inflammatory cytokines, including IL-1β and IL-18, subsequently leading to a type of cell death called pyroptosis. There are two types of signaling pathways involved in the process of inflammasome activation: the canonical and the non-canonical signaling pathway. The canonical signaling pathway is mainly dependent on casepase-1; the non-canonical signal pathway, which was recently discovered, is mainly dependent on caspase-11, but is also meditated by caspase-4, caspase-5, and caspase-8. Kidney inflammation is basically associated with inflammatory factor exudation and inflammatory cell infiltration. Several studies have showed that inflammasomes are closely related to kidney diseases, especially the NOD-, LRR- and pyrin domain-containing 3 (NLRP3) inflammasome, which play a role in regulating kidney inflammation and fibrosis. In this review, we focus on the relationship between inflammasomes and kidney diseases, especially the role of the NLRP3 inflammasome in different kinds of kidney disease via both canonical and non-canonical signal pathways.

Citing Articles

Caspase-4/11 promotes hyperlipidemia and chronic kidney disease-accelerated vascular inflammation by enhancing trained immunity.

Sun Y, Lu Y, Liu L, Saaoud F, Shao Y, Xu K JCI Insight. 2024; 9(16).

PMID: 39024553 PMC: 11343595. DOI: 10.1172/jci.insight.177229.

STUB1 exacerbates calcium oxalate-induced kidney injury by modulating reactive oxygen species-mediated cellular autophagy via regulating CFTR ubiquitination.

Hou Y, Huang C, Huang Z, Huang J, Zhu B Urolithiasis. 2024; 52(1):55.

PMID: 38564006 DOI: 10.1007/s00240-024-01547-6.

Fluorofenidone attenuates renal fibrosis by inhibiting lysosomal cathepsin‑mediated NLRP3 inflammasome activation.

Zheng L, Mei W, Zhou J, Wei X, Huang Z, Lin X Exp Ther Med. 2024; 27(4):142.

PMID: 38476910 PMC: 10928820. DOI: 10.3892/etm.2024.12430.

The Killer's Web: Interconnection between Inflammation, Epigenetics and Nutrition in Cancer.

Mecca M, Picerno S, Cortellino S Int J Mol Sci. 2024; 25(5).

PMID: 38473997 PMC: 10931665. DOI: 10.3390/ijms25052750.

Understanding the podocyte immune responses in proteinuric kidney diseases: from pathogenesis to therapy.

Jiang H, Shen Z, Zhuang J, Lu C, Qu Y, Xu C Front Immunol. 2024; 14:1335936.

PMID: 38288116 PMC: 10822972. DOI: 10.3389/fimmu.2023.1335936.

References

Qiu Y, Tang L . Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy. Pharmacol Res. 2016; 114:251-264. DOI: 10.1016/j.phrs.2016.11.004. View

Guo H, Bi X, Zhou P, Zhu S, Ding W . NLRP3 Deficiency Attenuates Renal Fibrosis and Ameliorates Mitochondrial Dysfunction in a Mouse Unilateral Ureteral Obstruction Model of Chronic Kidney Disease. Mediators Inflamm. 2017; 2017:8316560. PMC: 5350413. DOI: 10.1155/2017/8316560. View

Yang S, Ka S, Hua K, Wu T, Chuang Y, Lin Y . Antroquinonol mitigates an accelerated and progressive IgA nephropathy model in mice by activating the Nrf2 pathway and inhibiting T cells and NLRP3 inflammasome. Free Radic Biol Med. 2013; 61:285-97. DOI: 10.1016/j.freeradbiomed.2013.03.024. View

Chen Y, Yuan M, Xia M, Wang L, Zhang Y, Li P . Instant membrane resealing in nlrp3 inflammmasome activation of endothelial cells. Front Biosci (Landmark Ed). 2015; 21(3):635-50. PMC: 5507337. DOI: 10.2741/4411. View

van Bruggen R, Koker M, Jansen M, Van Houdt M, Roos D, Kuijpers T . Human NLRP3 inflammasome activation is Nox1-4 independent. Blood. 2010; 115(26):5398-400. DOI: 10.1182/blood-2009-10-250803. View

Vigano E, Diamond C, Spreafico R, Balachander A, Sobota R, Mortellaro A . Human caspase-4 and caspase-5 regulate the one-step non-canonical inflammasome activation in monocytes. Nat Commun. 2015; 6:8761. PMC: 4640152. DOI: 10.1038/ncomms9761. View

Tan X, Zheng X, Huang Z, Lin J, Xie C, Lin Y . Involvement of S100A8/A9-TLR4-NLRP3 Inflammasome Pathway in Contrast-Induced Acute Kidney Injury. Cell Physiol Biochem. 2017; 43(1):209-222. DOI: 10.1159/000480340. View

Chen W, Wang J, Luo Y, Wang T, Li X, Li A . Ginsenoside Rb1 and compound K improve insulin signaling and inhibit ER stress-associated NLRP3 inflammasome activation in adipose tissue. J Ginseng Res. 2016; 40(4):351-358. PMC: 5052408. DOI: 10.1016/j.jgr.2015.11.002. View

Koka S, Xia M, Zhang C, Zhang Y, Li P, Boini K . Podocyte NLRP3 Inflammasome Activation and Formation by Adipokine Visfatin. Cell Physiol Biochem. 2019; 53(2):355-365. PMC: 6794193. DOI: 10.33594/000000143. View

10.

Xu W, Wang L, Li J, Cai Y, Xue Y . TXNIP mediated the oxidative stress response in glomerular mesangial cells partially through AMPK pathway. Biomed Pharmacother. 2018; 107:785-792. DOI: 10.1016/j.biopha.2018.08.067. View

11.

Bi X, Wang J, Liu Y, Wang Y, Ding W . MnTBAP treatment ameliorates aldosterone-induced renal injury by regulating mitochondrial dysfunction and NLRP3 inflammasome signalling. Am J Transl Res. 2019; 10(11):3504-3513. PMC: 6291724. View

12.

Anders H, Suarez-Alvarez B, Grigorescu M, Foresto-Neto O, Steiger S, Desai J . The macrophage phenotype and inflammasome component NLRP3 contributes to nephrocalcinosis-related chronic kidney disease independent from IL-1-mediated tissue injury. Kidney Int. 2017; 93(3):656-669. DOI: 10.1016/j.kint.2017.09.022. View

13.

Hsu W, Hua K, Tuan L, Tsai Y, Chu L, Lee Y . Compound K inhibits priming and mitochondria-associated activating signals of NLRP3 inflammasome in renal tubulointerstitial lesions. Nephrol Dial Transplant. 2019; 35(1):74-85. DOI: 10.1093/ndt/gfz073. View

14.

Anders H, Lech M . NOD-like and Toll-like receptors or inflammasomes contribute to kidney disease in a canonical and a non-canonical manner. Kidney Int. 2013; 84(2):225-8. DOI: 10.1038/ki.2013.122. View

15.

Lavrik I, Krammer P . Regulation of CD95/Fas signaling at the DISC. Cell Death Differ. 2011; 19(1):36-41. PMC: 3252827. DOI: 10.1038/cdd.2011.155. View

16.

Komada T, Usui F, Kawashima A, Kimura H, Karasawa T, Inoue Y . Role of NLRP3 Inflammasomes for Rhabdomyolysis-induced Acute Kidney Injury. Sci Rep. 2015; 5:10901. PMC: 4456665. DOI: 10.1038/srep10901. View

17.

Schroder K, Tschopp J . The inflammasomes. Cell. 2010; 140(6):821-32. DOI: 10.1016/j.cell.2010.01.040. View

18.

He L, Peng X, Liu G, Tang C, Liu H, Liu F . Anti-inflammatory effects of triptolide on IgA nephropathy in rats. Immunopharmacol Immunotoxicol. 2015; 37(5):421-7. DOI: 10.3109/08923973.2015.1080265. View

19.

Yang K, Li W, Yu J, Yi C, Huang W . Diosmetin protects against ischemia/reperfusion-induced acute kidney injury in mice. J Surg Res. 2017; 214:69-78. DOI: 10.1016/j.jss.2017.02.067. View

20.

Yeung F, Hoberg J, Ramsey C, Keller M, Jones D, Frye R . Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 2004; 23(12):2369-80. PMC: 423286. DOI: 10.1038/sj.emboj.7600244. View